These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 36230843)

  • 81. Nanosensitizers for sonodynamic therapy for glioblastoma multiforme: current progress and future perspectives.
    Guo QL; Dai XL; Yin MY; Cheng HW; Qian HS; Wang H; Zhu DM; Wang XW
    Mil Med Res; 2022 Jun; 9(1):26. PubMed ID: 35676737
    [TBL] [Abstract][Full Text] [Related]  

  • 82. MRI Monitoring and Quantification of Ultrasound-Mediated Delivery of Liposomes Dually Labeled with Gadolinium and Fluorophore through the Blood-Brain Barrier.
    Aryal M; Papademetriou I; Zhang YZ; Power C; McDannold N; Porter T
    Ultrasound Med Biol; 2019 Jul; 45(7):1733-1742. PubMed ID: 31010598
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Blood-brain barrier disruption with low-intensity pulsed ultrasound for the treatment of pediatric brain tumors: a review and perspectives.
    Beccaria K; Canney M; Bouchoux G; Puget S; Grill J; Carpentier A
    Neurosurg Focus; 2020 Jan; 48(1):E10. PubMed ID: 31896084
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Multifunctional Theranostic Nanoparticles for Enhanced Tumor Targeted Imaging and Synergistic FUS/Chemotherapy on Murine 4T1 Breast Cancer Cell.
    Kang Z; Yang M; Feng X; Liao H; Zhang Z; Du Y
    Int J Nanomedicine; 2022; 17():2165-2187. PubMed ID: 35592098
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Multi-modality safety assessment of blood-brain barrier opening using focused ultrasound and definity microbubbles: a short-term study.
    Baseri B; Choi JJ; Tung YS; Konofagou EE
    Ultrasound Med Biol; 2010 Sep; 36(9):1445-59. PubMed ID: 20800172
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Sono-activated materials for enhancing focused ultrasound ablation: Design and application in biomedicine.
    Liao M; Du J; Chen L; Huang J; Yang R; Bao W; Zeng K; Wang W; Aphan BC; Wu Z; Ma L; Lu Q
    Acta Biomater; 2024 Jan; 173():36-50. PubMed ID: 37939816
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Ultrasound-guided therapeutic focused ultrasound: current status and future directions.
    Ebbini ES; ter Haar G
    Int J Hyperthermia; 2015 Mar; 31(2):77-89. PubMed ID: 25614047
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Ultrasound-targeted nucleic acid delivery for solid tumor therapy.
    Schwartz MR; Debski AC; Price RJ
    J Control Release; 2021 Nov; 339():531-546. PubMed ID: 34655678
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Nanoplatforms Potentiated Ablation-Immune Synergistic Therapy through Improving Local Control and Suppressing Recurrent Metastasis.
    Wei Z; Yu X; Huang M; Wen L; Lu C
    Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242696
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Engineered Extracellular Vesicles as a Targeted Delivery Platform for Precision Therapy.
    Sun Y; Sun F; Xu W; Qian H
    Tissue Eng Regen Med; 2023 Apr; 20(2):157-175. PubMed ID: 36637750
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Focused ultrasound as a treatment modality for gliomas.
    Nwafor DC; Obiri-Yeboah D; Fazad F; Blanks W; Mut M
    Front Neurol; 2024; 15():1387986. PubMed ID: 38813245
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Exploring the Impact of Irradiation on Glioblastoma Blood-Brain-Barrier Permeability: Insights from Dynamic-Contrast-Enhanced-MRI and Histological Analysis.
    Conq J; Joudiou N; Préat V; Gallez B
    Biomedicines; 2024 May; 12(5):. PubMed ID: 38791053
    [TBL] [Abstract][Full Text] [Related]  

  • 93. A Roadmap of CAR-T-Cell Therapy in Glioblastoma: Challenges and Future Perspectives.
    Montoya M; Gallus M; Phyu S; Haegelin J; de Groot J; Okada H
    Cells; 2024 Apr; 13(9):. PubMed ID: 38727262
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The role of focused ultrasound for pediatric brain tumors: current insights and future implications on treatment strategies.
    Chesney KM; Keating GF; Patel N; Kilburn L; Fonseca A; Wu CC; Nazarian J; Packer RJ; Donoho DA; Oluigbo C; Myseros JS; Keating RF; Syed HR
    Childs Nerv Syst; 2024 May; ():. PubMed ID: 38702518
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Nanoparticle-Based Combinational Strategies for Overcoming the Blood-Brain Barrier and Blood-Tumor Barrier.
    Lim SH; Yee GT; Khang D
    Int J Nanomedicine; 2024; 19():2529-2552. PubMed ID: 38505170
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Peritumoral brain zone in glioblastoma: biological, clinical and mechanical features.
    Ballestín A; Armocida D; Ribecco V; Seano G
    Front Immunol; 2024; 15():1347877. PubMed ID: 38487525
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Glioblastoma Therapy: Past, Present and Future.
    Obrador E; Moreno-Murciano P; Oriol-Caballo M; López-Blanch R; Pineda B; Gutiérrez-Arroyo JL; Loras A; Gonzalez-Bonet LG; Martinez-Cadenas C; Estrela JM; Marqués-Torrejón MÁ
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473776
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Advancements in Glioma Care: Focus on Emerging Neurosurgical Techniques.
    De Simone M; Conti V; Palermo G; De Maria L; Iaconetta G
    Biomedicines; 2023 Dec; 12(1):. PubMed ID: 38275370
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Preclinical Models and Technologies in Glioblastoma Research: Evolution, Current State, and Future Avenues.
    Slika H; Karimov Z; Alimonti P; Abou-Mrad T; De Fazio E; Alomari S; Tyler B
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003507
    [TBL] [Abstract][Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.